Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | CES1 | P23141 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Nitrobenzoic Acid SCHEMBL7727849 | 0.88 | TDP1 (0.72) | SRD5A2LMNAALDH1A1MAPTKDM4E | |
| Hydrogen Peroxide SCHEMBL28470548 | 0.87 | ALDH1A1 (0.55) | LMNAALDH1A1MAPTKDM4EUSP2 | |
| SCHEMBL254528 | 0.87 | ALDH1A1 (0.56) | LMNAGAAALDH1A1MAPTKDM4E | |
| SCHEMBL7727851 | 0.85 | ALDH1A1 (0.56) | LMNAALDH1A1MAPTKDM4EUSP2 | |
| SCHEMBL10723714 | 0.84 | SRD5A2 (0.83) | SRD5A2LMNAGAAALDH1A1MAPT | |
| SCHEMBL975118 | 0.84 | SRD5A2 (0.83) | SRD5A2LMNAGAAALDH1A1MAPT | |
| Methylamine SCHEMBL9733678 | 0.83 | ALDH1A1 (0.58) | LMNAALDH1A1MAPTKDM4EUSP2 | |
| SCHEMBL1148332 | 0.82 | CNR1 (0.58) | SRD5A2LMNAALDH1A1MAPTKDM4E | |
| SCHEMBL418825 | 0.82 | SRD5A2 (0.62) | SRD5A2LMNAGAAALDH1A1MAPT | |
| SCHEMBL3471178 | 0.82 | KDM4E (0.65) | LMNAGAAALDH1A1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0066153-B1 | 4-ISOPROPYL-4'-NITROBENZOPHENONE AND PROCESS FOR PREPARING IT | CASSELLA Aktiengesellschaft (DE) | 1984-10-03 | — | — | EP | claimed |
| US-4413144-A | 4-Isopropyl-4'-nitrobenzophenone and a process for the preparation of 4'-nitrobenzophenones substituted in the 4-position | CASSELLA AKTIENGESELLSCHAFT (DE) | 1983-11-01 | — | — | US | claimed |
| EP-0066153-A1 | 4-Isopropyl-4'-nitrobenzophenone and process for preparing it | CASSELLA Aktiengesellschaft (DE) | 1982-12-08 | — | — | EP | claimed |
| US-20140155382-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. (US) | 2014-06-05 | — | — | US | disclosed |
| EP-2651924-A1 | ANTI-VIRAL COMPOUNDS | Abbvie Inc. (US) | 2013-10-23 | — | — | EP | disclosed |
| WO-2012083164-A1 | ANTI-VIRAL COMPOUNDS | ABBOTT LABORATORIES (US) | 2012-06-21 | — | — | WO | disclosed |
| US-20120115918-A1 | Anti-Viral Compounds | ABBOTT LABORATORIES (US) | 2012-05-10 | — | — | US | disclosed |
| EP-0534314-B1 | Process for the preparation of nitrobenzophenones and also the colour-fast modification of a benzophenoneazopyridone dye | BASF AG (DE) | 1996-06-05 | — | — | EP | disclosed |
| US-5364972-A | Preparation of nitrobenzophenones, and a color-stable modification of a benzophenone-azopyridone dye | BASF AKTIENGESELLSCHAFT (DE) | 1994-11-15 | — | — | US | disclosed |
| EP-0534314-A2 | Process for the preparation of nitrobenzophenones and also the colour-fast modification of a benzophenoneazopyridone dye | BASF Aktiengesellschaft (DE) | 1993-03-31 | — | — | EP | disclosed |
| EP-0302401-A1 | Pyridone dyes, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1989-02-08 | — | — | EP | disclosed |
| EP-0066153-B1 | 4-ISOPROPYL-4'-NITROBENZOPHENONE AND PROCESS FOR PREPARING IT | CASSELLA Aktiengesellschaft (DE) | 1984-10-03 | — | — | EP | disclosed |
| EP-0066153-B1 | 4-ISOPROPYL-4'-NITROBENZOPHENONE AND PROCESS FOR PREPARING IT | CASSELLA Aktiengesellschaft (DE) | 1984-10-03 | — | — | EP | disclosed |
| US-4413144-A | 4-Isopropyl-4'-nitrobenzophenone and a process for the preparation of 4'-nitrobenzophenones substituted in the 4-position | CASSELLA AKTIENGESELLSCHAFT (DE) | 1983-11-01 | — | — | US | disclosed |
| US-4413144-A | 4-Isopropyl-4'-nitrobenzophenone and a process for the preparation of 4'-nitrobenzophenones substituted in the 4-position | CASSELLA AKTIENGESELLSCHAFT (DE) | 1983-11-01 | — | — | US | disclosed |
| US-4413144-A | 4-Isopropyl-4'-nitrobenzophenone and a process for the preparation of 4'-nitrobenzophenones substituted in the 4-position | CASSELLA AKTIENGESELLSCHAFT (DE) | 1983-11-01 | — | — | US | disclosed |
| EP-0066153-A1 | 4-Isopropyl-4'-nitrobenzophenone and process for preparing it | CASSELLA Aktiengesellschaft (DE) | 1982-12-08 | — | — | EP | disclosed |
| EP-0066153-A1 | 4-Isopropyl-4'-nitrobenzophenone and process for preparing it | CASSELLA Aktiengesellschaft (DE) | 1982-12-08 | — | — | EP | disclosed |
| EP-0066153-A1 | 4-Isopropyl-4'-nitrobenzophenone and process for preparing it | CASSELLA Aktiengesellschaft (DE) | 1982-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115918-A1 | Anti-Viral Compounds | HAVCR2, EIF2AK2, MAVS | SRD5A2 3423/4885LMNA 3118/4885GAA 223/4885 |
| US-20140155382-A1 | ANTI-VIRAL COMPOUNDS | HAVCR2, EIF2AK2, MAVS | SRD5A2 3423/4885LMNA 3118/4885GAA 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.